Alloimmunization as a Strategy for Vaccine Design against HIV/AIDS

This publication has 44 references indexed in Scilit:

• Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques
  European Journal of Immunology, 1999
• Comparison of four strategies for tumour vaccination in the B16-F10 melanoma model
  Gene Therapy, 1998
• Letter to the Editor: Concerning the Anti-Major Histocompatibility Complex Approach to HIV Type 1 Vaccine Design
  AIDS Research and Human Retroviruses, 1998
• Anti-Major Histocompatibility Complex Antibody Responses to Simian B Cells Do Not Protect Macaques against SIV_macInfection
  AIDS Research and Human Retroviruses, 1997
• Immunization with class I human histocompatibility leukocyte antigen can protect macaques against challenge infection with SIVmac-32H
  AIDS, 1995
• Alloimmunization as an AIDS Vaccine?
  Science, 1993
• Studies on the Specificity of the Vaccine Effect Elicited by Inactivated Simian Immunodeficiency Virus
  AIDS Research and Human Retroviruses, 1993
• Does the HIV envelope induce a chronic graft-versus-host-like disease?
  Immunology Today, 1992
• Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals.
  Journal of Clinical Investigation, 1989
• Viruses as immunological adjuvants in cancer
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1974